IL117629A - Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof - Google Patents

Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof

Info

Publication number
IL117629A
IL117629A IL11762996A IL11762996A IL117629A IL 117629 A IL117629 A IL 117629A IL 11762996 A IL11762996 A IL 11762996A IL 11762996 A IL11762996 A IL 11762996A IL 117629 A IL117629 A IL 117629A
Authority
IL
Israel
Prior art keywords
preparation
methods
pharmaceutical compositions
compositions containing
benzamide derivative
Prior art date
Application number
IL11762996A
Other languages
English (en)
Other versions
IL117629A0 (en
Original Assignee
Centaur Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/415,847 external-priority patent/US5643965A/en
Priority claimed from US08/415,694 external-priority patent/US5658953A/en
Priority claimed from US08/415,248 external-priority patent/US5659082A/en
Application filed by Centaur Pharmaceuticals Inc filed Critical Centaur Pharmaceuticals Inc
Publication of IL117629A0 publication Critical patent/IL117629A0/xx
Publication of IL117629A publication Critical patent/IL117629A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/38Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL11762996A 1995-04-03 1996-03-24 Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof IL117629A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41567795A 1995-04-03 1995-04-03
US08/415,847 US5643965A (en) 1995-04-03 1995-04-03 Aminobenzamide compounds for the treatment of neurodegenerative disorders
US08/415,694 US5658953A (en) 1995-04-03 1995-04-03 Pharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disorders
US08/415,248 US5659082A (en) 1995-04-03 1995-04-03 Nitro- and aminobenzamide compounds for neurodegenerative disorders

Publications (2)

Publication Number Publication Date
IL117629A0 IL117629A0 (en) 1996-07-23
IL117629A true IL117629A (en) 2000-08-13

Family

ID=27503636

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11762996A IL117629A (en) 1995-04-03 1996-03-24 Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof

Country Status (39)

Country Link
EP (1) EP0819113B1 (ar)
JP (1) JP3479658B2 (ar)
KR (1) KR100429120B1 (ar)
CN (1) CN1073552C (ar)
AR (1) AR002978A1 (ar)
AT (1) ATE202552T1 (ar)
AU (1) AU721045B2 (ar)
BG (1) BG63384B1 (ar)
CA (1) CA2215166A1 (ar)
CO (1) CO4700431A1 (ar)
CZ (1) CZ295852B6 (ar)
DE (1) DE69613567T2 (ar)
DK (1) DK0819113T3 (ar)
DZ (1) DZ2012A1 (ar)
EA (1) EA002031B1 (ar)
EE (1) EE03437B1 (ar)
ES (1) ES2160240T3 (ar)
GR (1) GR3036466T3 (ar)
HK (1) HK1016964A1 (ar)
HR (1) HRP960156B1 (ar)
HU (1) HUP9801759A3 (ar)
IL (1) IL117629A (ar)
IS (1) IS1919B (ar)
MA (1) MA23837A1 (ar)
MX (1) MX9707596A (ar)
MY (1) MY121206A (ar)
NO (1) NO318441B1 (ar)
NZ (1) NZ306204A (ar)
PL (1) PL184121B1 (ar)
PT (1) PT819113E (ar)
RO (1) RO116190B1 (ar)
SA (1) SA96160739B1 (ar)
SI (1) SI0819113T1 (ar)
SK (1) SK282900B6 (ar)
TN (1) TNSN96051A1 (ar)
TR (1) TR199701114T1 (ar)
TW (1) TW381073B (ar)
WO (1) WO1996031462A1 (ar)
YU (1) YU21096A (ar)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ332438A (en) * 1996-04-17 2001-02-23 Centaur Pharmaceuticals Inc Use of acetamido, amino or nitro substituted benzamide derivatives for treating of dementia associated with AIDS virus (HIV-1) infection
EP1034783B1 (en) * 1997-10-27 2004-12-15 Sumitomo Pharmaceuticals Company, Limited Amide derivatives for the treatment of retinal neurodegenerative disorders
AU3985699A (en) 1998-05-19 1999-12-06 Centaur Pharmaceuticals, Inc. Amide therapeutics for the treatment of inflammatory bowel disease
US6194465B1 (en) 1998-05-19 2001-02-27 Centaur Pharmaceuticals, Inc. Benzamide therapeutics for the treatment of inflammatory bowel disease
AU3679800A (en) * 1999-04-23 2000-11-10 Sumitomo Pharmaceuticals Company, Limited Apoptosis inhibitors
CN101817761B (zh) * 2010-01-29 2014-06-25 浙江大学 苯甲酸酯类衍生物及制备方法和应用
EP2535059A4 (en) * 2010-02-10 2014-03-12 Public Univ Corp Yokohama City USE OF A MSIN3B-BINDING COMPOUND WHICH BINDES SPECIFICLY TO THE SILENCER FACTOR OF NRSF NEURONIC SPECIFICATION
WO2014155184A1 (en) * 2013-03-28 2014-10-02 Rhenovia Pharma Treatment for parkinson's disease
CN115594603A (zh) * 2022-10-09 2023-01-13 湖北师范大学(Cn) 微通道反应器制备n-叔丁基-4-氨基苯甲酰胺的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1069882B (it) * 1975-12-22 1985-03-25 Mallinckrodt Inc 3 5 bis acilammino benzammidi particolarmente utili come agenti di contrasto per raffi x e procedimento per la loro preparazione
JPS5721320A (en) * 1980-07-11 1982-02-04 Chugai Pharmaceut Co Ltd Blood sugar level depressing agent
JPS5867657A (ja) * 1981-10-15 1983-04-22 Chugai Pharmaceut Co Ltd ペンズアミド誘導体
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions

Also Published As

Publication number Publication date
NZ306204A (en) 1999-01-28
IS4569A (is) 1997-09-25
DZ2012A1 (fr) 2002-07-21
CZ309897A3 (cs) 1998-12-16
IL117629A0 (en) 1996-07-23
TW381073B (en) 2000-02-01
EA002031B1 (ru) 2001-12-24
PL322625A1 (en) 1998-02-02
HRP960156A2 (en) 1997-10-31
HUP9801759A3 (en) 2001-06-28
PL184121B1 (pl) 2002-09-30
JP3479658B2 (ja) 2003-12-15
EE03437B1 (et) 2001-06-15
EP0819113B1 (en) 2001-06-27
MA23837A1 (fr) 1996-12-31
TNSN96051A1 (fr) 2005-03-15
AU721045B2 (en) 2000-06-22
SK132597A3 (en) 1998-09-09
NO318441B1 (no) 2005-03-21
BG101929A (en) 1998-04-30
SI0819113T1 (en) 2001-10-31
EA199700287A1 (ru) 1998-04-30
TR199701114T1 (xx) 1998-02-21
HUP9801759A2 (hu) 1998-12-28
ES2160240T3 (es) 2001-11-01
DK0819113T3 (da) 2001-10-15
ATE202552T1 (de) 2001-07-15
YU21096A (sh) 1999-03-04
CN1073552C (zh) 2001-10-24
MX9707596A (es) 1998-06-30
SK282900B6 (sk) 2003-01-09
CN1182416A (zh) 1998-05-20
BG63384B1 (bg) 2001-12-29
GR3036466T3 (en) 2001-11-30
MY121206A (en) 2006-01-28
JPH11501319A (ja) 1999-02-02
AR002978A1 (es) 1998-05-27
CZ295852B6 (cs) 2005-11-16
KR19980703562A (ko) 1998-11-05
DE69613567D1 (de) 2001-08-02
HRP960156B1 (en) 2002-04-30
NO974569D0 (no) 1997-10-02
IS1919B (is) 2004-03-15
EP0819113A1 (en) 1998-01-21
SA96160739B1 (ar) 2005-10-15
CO4700431A1 (es) 1998-12-29
CA2215166A1 (en) 1996-10-10
PT819113E (pt) 2001-10-30
EE9700235A (et) 1998-04-15
DE69613567T2 (de) 2002-04-18
HK1016964A1 (en) 1999-11-12
NO974569L (no) 1997-11-21
RO116190B1 (ro) 2000-11-30
KR100429120B1 (ko) 2004-08-18
AU5440496A (en) 1996-10-23
WO1996031462A1 (en) 1996-10-10

Similar Documents

Publication Publication Date Title
IL116673A0 (en) A pharmaceutical composition containing a benzimidazole derivative and processes for the preparation thereof
HUT77377A (hu) Aeroszol készítmények
IL119078A (en) Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them
GB9417524D0 (en) Pharmaceutical compositions
IL117659A0 (en) Acetamide derivative process for preparing the same and a pharmaceutical composition containing the same
GB9402203D0 (en) Pharmaceutical formulation
IL110376A0 (en) Pharmaceutical compositions containing ifetroban and methods for the preparation thereof
IL119080A0 (en) Pharmaceutical compositions containing tramadol
ZA958606B (en) A pharmaceutical formulation
IL113329A0 (en) Benzamide-containing pharmaceutical compositions
GB9418609D0 (en) Pharmaceutical compositions
GB9405856D0 (en) Pharmaceutical formulation
IL117495A0 (en) Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
HUP9602196A3 (en) Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof
IL115272A0 (en) Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof
IL117629A0 (en) Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof
ZA954469B (en) Pharmaceutical compositions
IL119603A0 (en) Amidinohydrazone derivatives methods for the preparation thereof and pharmaceutical compositions containing the same
ZA959081B (en) Pharmaceutical compositions
IL115981A0 (en) Cyclolignan derivatives procosses for the preparation thereof and pharmaceutical compositions containing the same
GB9406835D0 (en) Pharmaceutical compositions
GB2295825B (en) Pharmaceutical compositions
IL115537A0 (en) Phosphonosulfonate salts pharmaceutical compositions containing the same and methods for the preparation thereof
GB9400047D0 (en) Pharmaceutical compositions
HU9400096D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed